EDN1 and glomerulosclerosis: In addition, endothelin-1 (ET-1) has been associated with vasoconstriction, kidney injury, mesangial hyperplasia, glomerulosclerosis, fibrosis, and inflammation, and thus endothelin receptor antagonists have been proposed as potential treatments for DKD [10].